BioKangtai is a Chinese biopharmaceutical company that researches, develops, produces, and sells human vaccines across viral, bacterial, and mRNA platforms.
BioKangtai is an integrated producer of human immunisation products rather than a distributor of other companies' vaccines, covering research, development, production and sales of human vaccines. Its launched products include a 60-microgram hepatitis B vaccine, a dual-carrier 13-valent pneumococcal polysaccharide conjugate vaccine and a four-dose human diploid cell rabies vaccine.
BioKangtai differentiates itself through technological breadth across several vaccine classes, with a research platform covering live attenuated and inactivated viral vaccines, recombinant protein vaccines, bacterial polysaccharide and conjugate vaccines, combination vaccines, viral vector vaccines and mRNA vaccines. Its marketing and distribution network reaches every province, autonomous region and municipality directly under the Central Government across China.